Stoke Therapeutics, Inc.·4

Nov 18, 5:00 PM ET

Walker Robin A. 4

4 · Stoke Therapeutics, Inc. · Filed Nov 18, 2019

Insider Transaction Report

Form 4
Period: 2019-11-15
Walker Robin A.
Chief Legal Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2019-11-15+84,80084,800 total
    Exercise: $23.32Exp: 2029-11-14Common Stock (84,800 underlying)
Footnotes (1)
  • [F1]This option shall vest and become exercisable over a 4 year period: 25% of the total shares shall vest on November 12, 2020 and 1/48th of the total shares shall vest and become exercisable on the monthly anniversary thereafter, subject to reporting person's continued service through each vesting date.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4